Furthermore, as we targeted the EGFR tumor marker on the surface of tumor cells and tumor-secreted VEGF in the tumor microenvironment, this study could now be extended to include the surface epitopes of immune or stromal cells including fibroblasts and other secreted peptides or cytokines prevalent in the tumor microenvironment. The gene discussed is VEGFA; the disease is neoplasm.